Key clinical point: A single intra-articular injection of platelet-rich plasma showed better clinical outcomes than did weekly injections of hyaluronic acid in patients with hemophilic arthropathy of the knee.
Major finding: Pain and function scores were significantly lower in patients administered platelet-rich plasma versus hyaluronic acid at 6 months (P less than .05).
Study details: An open-label comparison study of 22 patients with hemophilia A.
Disclosures: The study was supported by grant funding from Tri-Service General Hospital in Taiwan. Three of the authors reported receiving research grants from Shire.
Li TY et al. Haemophilia. 2019 Mar 13. doi: 10.1111/hae.13711.